Disclosures for "ALUMNI AD Study Design: Evaluation of Subcutaneous Gantenerumab in Historically Underrepresented US Populations With Early Symptomatic Alzheimer’s Disease")
-
Sheila Seleri has received personal compensation for serving as an employee of Genentech, a member of the Roche group. Sheila Seleri has received stock or an ownership interest from Genentech, a member of the Roche group.
-
Dr. Brangman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Brangman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech-Roche. Dr. Brangman has received personal compensation in the range of $0-$499 for serving as a Consultant for Acadia. Dr. Brangman has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai. Dr. Brangman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Brangman has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Columbian Financial Group. Dr. Brangman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various Legal Firms. The institution of Dr. Brangman has received research support from National Institute on Aging. The institution of Dr. Brangman has received research support from NYS Health Foundation. The institution of Dr. Brangman has received research support from American Geriatrics Society.
-
Dr. Henderson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Henderson has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for International Association for Indigenous Aging. Dr. Henderson has received publishing royalties from a publication relating to health care.
-
Dr. Parker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Parker has received research support from NIH. Dr. Parker has received personal compensation in the range of $500-$4,999 for serving as a Patient Engagement Advisory Committee with FDA.
-
Ms. Monroe has received personal compensation for serving as an employee of UsAgainstAlzheimer's. Ms. Monroe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with University of Southern California.
-
Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AARP - Global Council on Brain Health. Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AARP - "Staying Sharp" Scientific Advisory Board. Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ACADIA. Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech (affiliate of F. Hoffmann-La Roche Ltd). Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health and Wellness Partners, LLC. Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ironshore Pharmaceuticals. Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving as a Consultant for Praxis Bioresearch. Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sygnature Discovery. Jacobo E. Mintzer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AARP - "Staying Sharp" Scientific Advisory Board. Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Study Title: NAB-It: Nabilone for Agitation Blinded Intervention Trial. Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Study Title: WeCareAdvisory Study. Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Technology Accelerator Company (TAC). Jacobo E. Mintzer has stock in Biopharma Connex. Jacobo E. Mintzer has stock in NeuroQuest. Jacobo E. Mintzer has stock in Recruitment Partners. The institution of Jacobo E. Mintzer has received research support from Eisai Inc.. The institution of Jacobo E. Mintzer has received research support from Alzheimer's Clinical Trials Consortium. The institution of Jacobo E. Mintzer has received research support from Eli Lilly and Company. The institution of Jacobo E. Mintzer has received research support from Alzheimer's Therapeutic Research Institute. The institution of Jacobo E. Mintzer has received research support from JHSPH Center for Clinical Trials. Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving as a Steering Committee Member with Alzheimer's Clinical Trials Consortium (ACTC). Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving as a Steering Committee Member with Alzheimer's Disease Cooperative Study (ADCS). Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving as a Steering Committee Member with Elder Court. Jacobo E. Mintzer has received personal compensation in the range of $0-$499 for serving as a Unpaid Consultant/Association Member with International Psychogeriatric Association (IPA).
-
Dr. Wise-Brown has received personal compensation for serving as an employee of Genentech.
-
Dr. Grundman has received personal compensation for serving as an employee of Global R&D Partners.
-
Dr. Smith has received personal compensation for serving as an employee of Roche Products Ltd. Dr. Smith has stock in Hoffman La Roche.
-
Rachelle Doody has nothing to disclose.
-
Dr. Lin has received personal compensation for serving as an employee of Genentech. Dr. Lin has stock in Genentech.
-
Beverly Assman has nothing to disclose.
-
Dr. Rippon has received personal compensation for serving as an employee of Genentech. Dr. Rippon has stock in Genentech.